Exendin-4通过Wnt通路减轻2型糖尿病大脑Alzheimer病样改变的机制

基本信息
批准号:81770817
项目类别:面上项目
资助金额:56.00
负责人:袁刚
学科分类:
依托单位:华中科技大学
批准年份:2017
结题年份:2021
起止时间:2018-01-01 - 2021-12-31
项目状态: 已结题
项目参与者:马德琳,徐惟捷,杜婷婷,刘莉,任会会,衡红艳,黄藤,刘娟宏
关键词:
胰岛素2型糖尿病阿尔茨海默病胰高血糖素样肽1
结项摘要

Type 2 diabetes mellitus (T2DM) increased the risk for developing Alzheimer's disease(AD), and brain insulin played a critical role in maintaining the pathophysiological changes of AD-associated tau protein. Recent studies have concluded that canonical Wnt signaling might be a therapeutic target for AD treatment. In our previous work, we found that brain insulin was decreased and tau protein was hyperphosphorylated. Exendin-4(Ex-4), a GLP-1 receptor agonist increased the level of brain insulin, as well as ameliorated AD-like tau changes. Moreover, EX-4 could activate Wnt signaling and the Wnt signaling was closely related with insulin production. Thus, Wnt signaling might be involved in the development of AD in T2DM by Ex-4. Based on those findings, using insulin or β-catenin central knockout mice and adenovirus-mediated transfection, we will further investigate: (1) the molecular mechanisms of Wnt signaling in the regulation of AD in T2DM by Ex-4; (2) the mechanisms of “crosstalk between nuclear factors”contributing to the production of brain insulin by activated Wnt signaling. Our study will further clarify the role of Ex-4 and Wnt signaling in the regulation of brain insulin, which might provide more evidence for decreasing the risk of AD in T2DM.

2型糖尿病(T2DM)已成为Alzheimer病(AD)的发病风险。研究显示,大脑胰岛素在维持AD相关性病理生理变化中起到重要作用,经典Wnt通路可能是治疗AD的靶点。本课题组前期研究发现:T2DM时大脑胰岛素下降合并tau蛋白AD相关病变,GLP-1受体激动剂Ex-4可增加大脑胰岛素并减轻tau蛋白AD相关病变;进而发现:Ex-4可激活Wnt通路,而后者与胰岛素生成密切相关。因此,Wnt通路的激活可能是Ex-4通过提高大脑胰岛素水平改善T2DM时AD相关性病变的关键环节。本课题将利用insulin、β-catenin中枢特异性条件敲除小鼠和腺病毒转染等方法,开展以下研究:1揭示Wnt通路参与Ex-4改善T2DM大脑胰岛素水平的现象;2阐明Wnt通路通过“核因子对话”产生胰岛素和改善AD相关性病变的分子机制。本课题的开展,将有助于全面揭示Ex-4通过Wnt通路降低T2DM时AD病变的机制。

项目摘要

2型糖尿病(T2DM)已成为Alzheimer病(AD)的发病风险。T2DM发生AD的风险显著高于非T2DM人群,且T2DM与AD目前均无治愈手段,因此防治及逆转T2DM时AD的早期病变已成为治疗的关键。研究显示,大脑胰岛素在维持AD相关性病理生理变化中起到重要作用,经典Wnt通路可能是治疗AD的靶点。因此本研究的主要内容为:1.揭示Wnt通路参与Ex-4改善T2DM大脑胰岛素水平的现象;2.阐明Wnt通路通过“核因子对话”产生胰岛素和改善AD相关性病变的分子机制。本课题组通过细胞及动物实验研究发现:1.Ex-4通过促进脑胰岛素分泌改善T2DM相关AD早期病变;2. Ex-4通过激活经典Wnt通路促进脑胰岛素的分泌;3. Ex-4激活经典Wnt通路后通过调控NeuroD1因子促进脑胰岛素生成。本课题的开展,进一步阐述了 Ex-4 通过经典 Wnt 信号通路改善 T2DM 时 tau 蛋白 AD 相关性病变的作用机制及部分调控网络,有助于全面揭示Ex-4通过Wnt通路降低T2DM时AD病变的机制,对于揭示 T2DM、AD 等疾病的病理生理过程乃至药物靶点的开发均具有重要的科学意义和社会经济学效益。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

DOI:10.7498/aps.67.20171903
发表时间:2018
3

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
4

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
5

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:

相似国自然基金

1

黄连解毒汤对2型糖尿病大鼠Alzheimer病样tau蛋白磷酸化修饰及机制研究

批准号:81303283
批准年份:2013
负责人:伍文彬
学科分类:H3211
资助金额:23.00
项目类别:青年科学基金项目
2

GLP-1通过上调大脑AMPK/PGC1α通路降低2型糖尿病并发帕金森病风险的机制研究

批准号:81500636
批准年份:2015
负责人:马德琳
学科分类:H0708
资助金额:18.00
项目类别:青年科学基金项目
3

Wnt信号通路与2型糖尿病遗传易感性初步探索

批准号:81300650
批准年份:2013
负责人:周建博
学科分类:H0708
资助金额:24.00
项目类别:青年科学基金项目
4

糖肾宁调控 Wnt/β-catenin 通路减轻糖尿病肾病足细胞 EMT 作用机制研究

批准号:81703989
批准年份:2017
负责人:崔方强
学科分类:H3108
资助金额:20.00
项目类别:青年科学基金项目